glp-1 drugs pharmaceutical companies partnerships 2025 Market Size to Hit USD 212.73 Billion by 2035 GLP-1 Market Trends and Global

government data shows, and around 12% say they currently take GLP-1 drugs, according to a poll published last month by health policy research organization KFF

Sit on the toilet with feet elevated on a stool for 5-10 minutes

However, GLP-1s can come with challenges, including gastrointestinal side effects, risk of micronutrient deficiencies, muscle and bone loss, poor long-term follow through with weight regain if stopped, and high costs

The Reward System: GLP-1 also modulates the brains reward pathways, particularly areas rich in dopamine receptors

For obesity alone, you must use FDA-approved Wegovy, not off-label diabetes drugs